BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Covington
Accenture
Cipla
Argus Health
McKinsey
Healthtrust
Cantor Fitzgerald
Novartis
Mallinckrodt

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077789

« Back to Dashboard

NDA 077789 describes CHLORHEXIDINE GLUCONATE, which is a drug marketed by Sage Prods, Apotex Inc, Hi Tech Pharma, Lyne, Teva, Wockhardt, Xttrium, Becton Dickinson, and Kendall Il, and is included in nine NDAs. It is available from twenty-seven suppliers. There are five patents protecting this drug. Additional details are available on the CHLORHEXIDINE GLUCONATE profile page.

The generic ingredient in CHLORHEXIDINE GLUCONATE is chlorhexidine gluconate. There are fifty-seven drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Summary for 077789
Tradename:CHLORHEXIDINE GLUCONATE
Applicant:Xttrium
Ingredient:chlorhexidine gluconate
Patents:0
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 077789
Physiological EffectDecreased Cell Wall Integrity
Medical Subject Heading (MeSH) Categories for 077789
Suppliers and Packaging for NDA: 077789
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLORHEXIDINE GLUCONATE chlorhexidine gluconate SOLUTION;DENTAL 077789 ANDA Xttrium Laboratories, Inc. 0116-2001 0116-2001-16 473 mL in 1 BOTTLE (0116-2001-16)
CHLORHEXIDINE GLUCONATE chlorhexidine gluconate SOLUTION;DENTAL 077789 ANDA Xttrium Laboratories, Inc. 0116-2001 0116-2001-15 15 mL in 1 BOTTLE (0116-2001-15)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;DENTALStrength0.12%
Approval Date:Jun 18, 2009TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Medtronic
Queensland Health
Teva
Chinese Patent Office
Julphar
Boehringer Ingelheim
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot